Wird geladen...
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular (CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of antidiabetic medication that inhibit the absorption of glucose from the proximal tubule of the kidney and hence cause gly...
Gespeichert in:
| Veröffentlicht in: | Int J Environ Res Public Health |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6720282/ https://ncbi.nlm.nih.gov/pubmed/31426529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph16162965 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|